Catherine Kielar

Catherine Kielar serves as the Executive Director and Global Market Access Practice lead at Avalere Health since October 2023. With extensive experience at PRMA Consulting Ltd from February 2021 to the present, previous roles include Senior Director and Associate Director, specializing in market access strategy and reimbursement activities across various disease areas such as oncology and infectious diseases. Prior positions include Principal Consultant at Staatz Business Development & Strategy and Market Access Consultant at OPEN Access Consulting, alongside freelance consultancy at Cell Medica. Catherine's earlier experience includes roles at Roche and HERON - A PAREXEL COMPANY, focusing on HTA submissions and medical communication. Academic qualifications include a PhD in Neuroscience from King's College London and a Master’s in Health Economics and Decision Modelling from The University of Sheffield, complemented by additional Master's degrees in Human Genetics and Biochemistry.